Ongoing Registry of Treatment of Venous Thromboembolism

NCT03881345 | Recruiting

• 1 other identifier: A002
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.

Conditions

Deep Vein Thrombosis; Thromboses, Venous; Thrombosis Embolism; Postthrombotic Syndrome; Pulmonary Embolism

Outcome Measures

Primary Outcomes (1)

• Veins patency

  Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods

  Baseline, 3 and 12 months post-intervention

Secondary Outcomes (3)

• Postthrombotic syndrome

  Baseline, 3 and 12 months post-intervention

• QoL SF-36

  Baseline, 3 and 12 months post-intervention

• QoL AVVQ

  Baseline, 3 and 12 months post-intervention

Interventions

Anticoagulants DRUG

anticoagulation according to the main diagnosis

Open surgery PROCEDURE

removal of blood clots with open surgery

Thrombolysis PROCEDURE

removal of blood clots with thrombolysis

Venous stenting PROCEDURE

elimination of vein obstruction by stenting

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients undergoing any kind of treatment for venous thromboembolism

You may qualify if:

• case of venous thrombosis of a limb or pulmonary embolus

Sponsors & Collaborators

• Medalp Private Surgery Clinic: lead
• State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia: collaborator

Study Sites (1)

Pirogov Russian National Research Medical University

Moscow, Moscow, 190000, Russia

RECRUITING

Related Links

• Russian Registry of Treatment of Venous Thromboembolism (RRT VTE)
• Russian Phlebological Association (RPA)

MeSH Terms

Conditions

Venous Thrombosis; Embolism and Thrombosis; Postthrombotic Syndrome; Pulmonary Embolism

Interventions

Anticoagulants; Conversion to Open Surgery; Fibrinolytic Agents

Condition Hierarchy (Ancestors)

Thrombosis; Vascular Diseases; Cardiovascular Diseases; Venous Insufficiency; Lung Diseases; Respiratory Tract Diseases; Embolism

Intervention Hierarchy (Ancestors)

Hematologic Agents; Therapeutic Uses; Pharmacologic Actions; Chemical Actions and Uses; Endoscopy; Minimally Invasive Surgical Procedures; Surgical Procedures, Operative; Fibrin Modulating Agents; Molecular Mechanisms of Pharmacological Action; Cardiovascular Agents

Central Study Contacts

Evgeny Ilyukhin

CONTACT

+79218451722; evgeny@ilyukhin.info

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 17, 2019
• First Posted: March 19, 2019
• Study Start: April 1, 2019
• Primary Completion (Estimated): March 1, 2036
• Study Completion (Estimated): March 1, 2036
• Last Updated: May 8, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

RU (1)